AMSTERDAM (MedPage Today) -- Smokers with metastatic non-small cell lung cancer responded more than twice as often as nonsmokers to a targeted therapy that improves immunologic activity against cancer cells, a preliminary trial showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment